Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker

Clinical Chemistry

Volumn 53, Issue 4, 2007, Pages 629-635

  Melle, Christian ^a   Ernst, Günther ^a   Escher, Niko ^a   Hartmann, Daniel ^b   Schimmel, Bettina ^a   Bleul, Annett ^a   Thieme, Heike ^a   Kaufmann, Roland ^a   Felix, Klaus ^b   Friess, Helmut M ^b   Settmacher, Utz ^a   Hommann, Merten ^a   Richter, Konrad K ^a   Daffner, Wolfgang ^a   Täubig, Horst ^c   Manger, Thomas ^c   Claussen, Uwe ^a   Von Eggeling, Ferdinand ^a,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SRH Wald Klinikum Gera   (Germany)

^d CUCA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; HEAT SHOCK PROTEIN 27; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; PANCREAS ADENOCARCINOMA; PEPTIDE MAPPING; PREOPERATIVE EVALUATION; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADENOCARCINOMA; BLOTTING, WESTERN; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34147220062     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.079194     Document Type: Article

References (32)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55;10-30.
2. Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol 2005;23:4524-31.
3. Tang N, Tornatore P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004;23:34-44.
4. Melle C, Ernst G, Schimmel B, Bleul A, Thieme H, Kaufmann R, et al. Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 2005;129:66-73.
5. Wright GL, Cazares LH, Leung SM, Nasim S, Adam BL, Yip TT, et al. Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 1999;2:264-76.
6. von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U, et al. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques 2000;1066-70.
7. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002;8:2541-52.
8. - lymphocytes of patients with cutaneous T-cell lymphoma. Eur J Cancer 2006;42:249-5
9. Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC, et al. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 2004;64:5929-33.
10. Kwapiszewska G, Meyer M, Bogumil R, Bohle RM, Seeger W, Weissmann N, et al. Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS. BMC Biotechnol 2004;4:30.
11. Melle C, Ernst G, Schimmel B, Bleul A, Kaufmann R, Hommann M, et al. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach. J Proteome Res 2005;4:1799-804.
12. Melle C, Ernst G, Schimmel B, Bleul A, Koscielny S, Wiesner A, et al. Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip® technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry. Mol Cell Proteomics 2003; 2:443-52.
13. van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
14. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-9.
15. Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, et al. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Mod Pathol 2005;18:779-87.
16. Segara D, Biankin AV, Kench JG, Langusch CC, Dawson AC, Skalicky DA, et al. Expression of H0XB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia. Clin Cancer Res 2005;11:3587-96.
17. Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005;4:1742-51.
18. Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, et al. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 2005;129:1187-97.
19. Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, et al. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003;3:1988-2001.
20. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002; 62:1868-75.
21. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10:860-8.
22. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S, et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 2005;65:10613-22.
23. Melle C, Osterloh D, Ernst G, Schimmel B, Bleul A, von Eggeling F. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry. Int J Mol Med 2005;16:11-7.
24. Hod Y. Differential control of apoptosis by DJ-1 in prostate benign and cancer cells. J Cell Biochem 2004;92:1221-33.
25. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 1997;231:509-13.
26. Sekito A, Taira T, Niki T, Iguchi-Ariga SM, Ariga H. Stimulation of transforming activity of DJ-1 by Abstrakt, a DJ-1-binding protein. Int J Oncol 2005;26:685-9.
27. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263-73.
28. Chen J, Kahne T, Rocken C, Gotze T, Yu J, Sung JJ, et al. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res 2004;3:1009-16.
29. Garrido C, Schmitt E, Cande C, Vahsen N, Parcellier A, Kroemer G. HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle 2003;2:579-84.
30. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005;10:86-103.
31. Gangarosa LM, Grove PS, Chang WWL. Heat shock proteins and pancreatic adenocarcinoma. Gastroenterology 1999;116: A1127.
32. Lu Z, Hu L, Evers S, Chen J, Shen Y. Differential expression profiling of human pancreatic adenocarcinoma and healthy pancreatic tissue. Proteomics 2004;4:3975-88.